Abstract:The convenient and precise fabrication of drug-hydrogel formulations with satisfactory degradability and a well-controlled drug release profile are crucial factors for injectable hydrogel formulations in clinical applications. Here a new injectable thermosensitive hydrogel formed from poly(ε-caprolactone) (PCL)-poly(ethylene glycol)-poly(ε-caprolactone) amphiphilicco-polymers with 1,4,8-trioxa[4.6]spiro-9-undecanone (TOSUO) moieties incorporated in the poly(ε-caprolactone) (PCL)block (PECT) was constructed to provide a route to tailor the degradation and drug release behavior. The effect of hydrophilic cyclic ether moieties on the degradation of and drug release by PECT hydrogels were evaluated in vitro and in vivo. The results indicated that a freeze-dried powder of paclitaxel-loaded PECT nanoparticles rapidly dissolved in water at ambient temperature with slightly shaking and formed a stable injectable in situ drug-hydrogel formulation at body temperature, which is convenient for clinical operations because it avoids the need for pre-quenching or long-term incubation. The paclitaxel distribution was also more quantitative and homogeneous on entrapping paclitaxel in PECT nanoparticles. Further, the small number of pendant cyclic ether groups in PCL could decrease the cystallinity and hydrophobicity and, as a result, the in vitro and in vivo retention time of PECT hydrogels and the release of entrapped paclitaxel could be tuned from a few weeks to months by varying the amount of PTOSUO in the hydrophobic block. Significantly, paclitaxel-loaded PECT nanoparticles and free paclitaxel could be simultaneously released during the in vitro paclitaxel release from PECT hydrogels. A histopathological evaluation indicated that in vivo injected PECT hydrogels produced only a modest inflammatory response. Thus pendant cyclic ether modification of PCL could be an effective way to achieve the desired degradation and drug release profiles of amphiphilicco-polymer thermosensitive hydrogels and PECT hydrogels may be suitable for local drug delivery.

Study on the in vitro release of tetanus toxo id from polylactide microspheres and the influence of additives on the drug release

Effect of Hydrophilic/hydrophobic Additives on Protein Release from PLGA Microspheres

Study on Preparative Conditions for Polylactide Microspheres Containing Tetanus Toxoid

Formulation Aspects of Protein Stability and Complete Release in Poly(Lactic-co-glycolic acid)Microspheres

Adjustable Degradation and Drug Release of a Thermosensitive Hydrogel Based on a Pendant Cyclic Ether Modified Poly(ε-Caprolactone) and Poly(ethylene Glycol)co-Polymer

Study on Release of Recombinant Human Growth Hormone Poly Lactice-Co-glytic Acid Microspheres in Vitro and the Effects of Additives

Modulating Drug Release from Short Poly(ethylene Glycol) Block Initiated Poly(L-lactide) Di-block Copolymers

[Preparation, Characterization and Drug Release Characteristics of Poly(lactide)(pl)/poly(lactide-Co-polyethylene Glycol)(pleg) Blend Microspheres].

Effects of Additives and Processing Parameters on the Initial Burst Release of Protein from Poly(lactic-Co-glycolic Acid) Microspheres.

The Effects of Lactidyl/Glycolidyl Ratio and Molecular Weight of Poly(D,L-Lactide-Co-Glycolide) on the Tetracycline Entrapment and Release Kinetics of Drug-Loaded Nanofibers

Different Ph-Values of Release Medium Influence the Drug Release from PTX-PCL Microspheres

Preparation, Characterization And In Vitro Release Properties Of Ibuprofen-Loaded Microspheres Based On Polylactide, Poly(Epsilon-Caprolactone) And Their Copolymers

Improvement of protein loading and modulation of protein release from poly(lactide-co-glycolide) microspheres by complexation of proteins with polyanions.

Preparation and properties of vancomycin-loaded PLA-PEG-PLA microspheres by electrostatic spray technology

Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(ε-caprolactone) and their copolymers

Freeze-drying and in vitro release kinetics of poly(ethylene glycol)Poly(dl-lactide) block copolymer micelles

The Effect of Ph on the Polymer Degradation and Drug Release from PLGA‐mPEG Microparticles

Immunogenicity of Single-Dose Delivery of Tetanus Toxoid Encapsulated in Microspheres

In Vitro Evaluation of Lysozyme-loaded Microspheres in Thermosensitive Methylcellulose-based Hydrogel

Fabrication and in vitro drug release study of microsphere drug delivery systems based on amphiphilic poly-α,β-[N-(2-hydroxyethyl)-l-aspartamide]-g-poly(l-lactide) graft copolymers

Effect of drug-polymer interaction on the release characteristics of methacrylic acid copolymer microcapsules containing theophylline